OVSTAR TIL Trial (OVarian Cancer Co-STimulatory Antigen Receptor TIL Trial)
Phase 1
Withdrawn
- Conditions
- Ovarian Cancer Metastatic
- Interventions
- Genetic: Gene modified Tumour Infiltrating Lymphocytes (CoTIL-01)Genetic: Unmodified Tumour Infiltrating Lymphocytes (UTIL-01)
- First Posted Date
- 2020-05-15
- Last Posted Date
- 2020-12-16
- Lead Sponsor
- Immetacyte Ltd
- Registration Number
- NCT04389229
- Locations
- 🇬🇧
The Christies Hospital, Manchester, United Kingdom
🇬🇧Queens Elizabeth Hospital, Birmingham, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath